175 related articles for article (PubMed ID: 7379916)
1. Biological activity of the C-terminal octapeptide of cholecystokinin, of three of its analogues and of caerulein in the dog.
Meyer FD; Gyr K; Kayasseh L; Jeker L; Wall M; Trzeciak A; Gillessen D
Experientia; 1980 Apr; 36(4):434-6. PubMed ID: 7379916
[TBL] [Abstract][Full Text] [Related]
2. Exocrine pancreatic secretion in response to a new CCK-analog, CCK33 and caerulein in dogs.
Beglinger C; Solomon TE; Gyr K; Moroder L; Wünsch E
Regul Pept; 1984 Jul; 8(4):291-6. PubMed ID: 6548569
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
[TBL] [Abstract][Full Text] [Related]
4. [Chemical structure and biological activity of cholecystokizin octapeptides with respect to the stomach and pancreas].
Beglinger C; Meyer F; Gyr K; Kayasseh L; Jeker L; Stalder GA; Rittmann WW
Schweiz Med Wochenschr; 1980 May; 110(22):861-2. PubMed ID: 6250210
[TBL] [Abstract][Full Text] [Related]
5. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog.
Meyer FD; Gyr K; Häcki WH; Beglinger C; Jeker L; Varga L; Kayasseh L; Gillessen D; Stalder GA
Gastroenterology; 1981 Apr; 80(4):742-7. PubMed ID: 7202946
[TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
Zetler G
Neuropharmacology; 1982 Aug; 21(8):795-801. PubMed ID: 6289160
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S
J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
[TBL] [Abstract][Full Text] [Related]
9. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and biological activities of methoxinine-analogues of the C-terminal octapeptide of cholecystokinin-pancreozymin.
Gillessen D; Trzeciak A; Müller RK; Studer RO
Int J Pept Protein Res; 1979 Feb; 13(2):130-6. PubMed ID: 429089
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.
Zetler G
Neuropharmacology; 1983 Jun; 22(6):757-66. PubMed ID: 6310434
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic secretory response to cholecystokinin-pancreozymin and caerulein in the conscious rat.
Laugier R; Papp A; Demol P; Charbit JJ; Sarles H
Pflugers Arch; 1980 Mar; 384(1):83-92. PubMed ID: 7189871
[No Abstract] [Full Text] [Related]
13. Structure-activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in mice.
Kádár T; Pesti A; Penke B; Tóth G; Zarándi M; Telegdy G
Neuropharmacology; 1983 Oct; 22(10):1223-9. PubMed ID: 6316193
[TBL] [Abstract][Full Text] [Related]
14. The action of scretin, cholecystokinin-pancreozymin and caerulein on pancreatic secretion in the rat.
Dockray GJ
J Physiol; 1972 Sep; 225(3):679-92. PubMed ID: 5076393
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro.
Konturek SJ; Bilski J; Jaworek J; Mochizuki T; Yanaihara C; Yanaihara N
Regul Pept; 1989 Mar; 24(3):301-11. PubMed ID: 2469109
[TBL] [Abstract][Full Text] [Related]
16. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Scarpignato C; Varga G; Dobronyi I; Papp M
Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
[TBL] [Abstract][Full Text] [Related]
17. The action of the C-terminal octapeptide of cholecystokinin and related peptides on pancreatic exocrine secretion.
Nakajima S
Gut; 1973 Aug; 14(8):607-15. PubMed ID: 4743491
[TBL] [Abstract][Full Text] [Related]
18. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.
Zetler G
Peptides; 1982; 3(4):701-4. PubMed ID: 6291014
[TBL] [Abstract][Full Text] [Related]
19. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
[TBL] [Abstract][Full Text] [Related]
20. Caerulein-induced acute pancreatitis in the rat. Pancreatic secretory response to cholecystokinin.
San Román JI; De Dios I; Manso MA; Calvo JJ; López MA
Arch Int Physiol Biochim; 1990 Oct; 98(5):237-43. PubMed ID: 1708991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
